Article

How Well Do You Know Practice Recommendations for Psoriatic Arthritis?

Are you up-to-date on the latest recommendations for PsA from EULAR and GRAPPA? Take our 6-question quiz to find out.

New evidence and the availability of novel therapeutic agents prompted the European League Against Rheumatism (EULAR)1,2 and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)3,4 to update their practice recommendations for psoriatic arthritis (PsA) in 2015.

How well do you know the latest EULAR and GRAPPA guidelines on PsA? Test your knowledge with this 6-question quiz.

1. GRAPPA 2015 included updated treatment recommendations for which of the following symptoms of PsA?

A. Arthritis and spondylitis

B. Enthesitis and dactylitis

C. Skin and nail disease

D. All of the above


References:

1. Gossec L, Smolen JS, Gaujoux-Viala C, et al. European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies. Ann Rheum Dis. 2012;71:4-12.

2. Gossec L, Smolen JS, Ramiro S, et al. European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update. Ann Rheum Dis. 2016;75:499-510.

3. Ritchlin CT, Kavanaugh A, Gladman DD, et al. Treatment recommendations for psoriatic arthritis. Arthritis Rheumatol. 2016;68:1060-1071.

4. Coates LC, Kavanaugh A, Mease PJ, et al. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis. Arthritis Rheumatol. 2016;68:1060-1071.

Links to Full Text of Guidelines:

EULAR 2015: http://ard.bmj.com/content/75/3/499.long

GRAPPA 2015: https://onlinelibrary.wiley.com/doi/epdf/10.1002/art.39573

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
© 2024 MJH Life Sciences

All rights reserved.